Stemedica Issued U.S. Patent For Stem Cell Treatment of Diabetic…

Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors announced that the Company has been issued U.S. Patent #8,318,485 by the United States...

(PRWeb December 20, 2012)

Read the full story at http://www.prweb.com/releases/stemedica-stem-cells/diabetic-retinopathy/prweb10257473.htm